Mark Johnson

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 2

Top Topics

Signaling Pathway

Antiretroviral Therapy

Top Venues

Antimicrobial agents and chemotherapy

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Teodora Pene Dumitrescu, Samit R Joshi, Jianfeng Xu, Joyce Zhan, Mark Johnson, Laurie Butcher, Eric Zimmerman, Lindsey Webster, Antonia M Davidson, Max Lataillade, Sherene Min
A Phase I Evaluation of the Pharmacokinetics and Tolerability of the HIV-1 Maturation Inhibitor GSK3640254 and Tenofovir Alafenamide/Emtricitabine in Healthy Participants. Antimicrobial agents and chemotherapy 65 (6) (2021)
Mark Johnson, Roxanne C Jewell, Amanda Peppercorn, Elizabeth Gould, Jianfeng Xu, Yu Lou, Matthew Davies, Sandra Baldwin, Allan R Tenorio, Matthew Burke, Jerry Jeffrey, Brian A Johns
The safety, tolerability, and pharmacokinetic profile of GSK2838232, a novel 2nd generation HIV maturation inhibitor, as assessed in healthy subjects. Pharmacology research & perspectives 6 (4) (2018)